Fisher Asset Management, LLC

Position in SRRK — Scholar Rock Holding Corp

CIK 850529 PLANO, TX

Position in SRRK

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$24,169,585

+$1,653,470 QoQ

Shares Held

439,447

-4.1% QoQ

Ownership

0.361%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#49

of 304 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 22% Shared 0% None 78%

Healthcare · as of Jun 30, 2026

Fisher Asset Management, LLC holds $807,507,065 across 59 Biotechnology names. SRRK ranks #14 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	957,691	$78,061,393
2	RCUS	Arcus Biosciences, Inc.	2,139,396	$65,957,578
3	CYTK	Cytokinetics Inc	743,697	$63,355,547
4	DNLI	Denali Therapeutics Inc.	2,414,162	$62,092,246
5	RVMD	Revolution Medicines, Inc.	207,693	$38,896,745
6	LGND	Ligand Pharmaceuticals Inc	121,440	$38,385,969
7	CLDX	Celldex Therapeutics, Inc.	985,677	$36,677,041
8	HALO	Halozyme Therapeutics, Inc.	427,713	$33,477,096

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$24,169,585	439,447	-4.1%	Shares	Defined	2026-08-04
2026-03-31	$22,516,115	458,017	-13.8%	Shares	Defined	2026-05-05
2025-12-31	$23,409,887	531,439	-0.3%	Shares	Defined	2026-02-09
2025-09-30	$19,855,474	533,176	+29.3%	Shares	Defined	2025-11-12
2025-06-30	$14,607,597	412,411	-9.7%	Shares	Defined	2025-08-13
2025-03-31	$14,688,402	456,871	-17.6%	Shares	Defined	2025-05-14
2024-12-31	$23,975,733	554,737	-24.4%	Shares	Defined	2025-02-05
2024-09-30	$5,879,492	734,019	+593.6%	Shares	Defined	2024-11-12
2024-06-30	$881,588	105,833	0.0%	Shares	Defined	2024-08-14
2024-03-31	$1,879,594	105,833	-6.5%	Shares	Defined	2024-05-09
2023-12-31	$2,127,483	113,164	-19.8%	Shares	Defined	2024-03-05
2023-09-30	$1,001,490	141,055	0.0%	Shares	Sole	2023-11-13
2023-06-30	$1,063,554	141,055	—	Shares	Sole	2023-12-12
No filing history on record for this holder in this stock.